{"protocolSection": {"identificationModule": {"nctId": "NCT01210170", "orgStudyIdInfo": {"id": "20071188"}, "secondaryIdInfos": [{"id": "P05299", "type": "OTHER", "domain": "Sponsor"}], "organization": {"fullName": "University of Miami", "class": "OTHER"}, "briefTitle": "Acute Effect of Mometasone on Beta-adrenergic Airway and Airway Vascular Relaxation in Severe Asthma", "officialTitle": "Acute Effect of Mometasone Furoate DPI on Beta-adrenergic Airway and Airway Vascular Relaxation in Moderately Severe Asthma"}, "statusModule": {"statusVerifiedDate": "2017-10", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2010-10"}, "primaryCompletionDateStruct": {"date": "2013-02", "type": "ACTUAL"}, "completionDateStruct": {"date": "2013-02", "type": "ACTUAL"}, "studyFirstSubmitDate": "2010-09-27", "studyFirstSubmitQcDate": "2010-09-27", "studyFirstPostDateStruct": {"date": "2010-09-28", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2014-09-05", "resultsFirstSubmitQcDate": "2014-11-17", "resultsFirstPostDateStruct": {"date": "2014-11-19", "type": "ESTIMATED"}, "lastUpdateSubmitDate": "2017-10-20", "lastUpdatePostDateStruct": {"date": "2017-11-21", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "PRINCIPAL_INVESTIGATOR", "investigatorFullName": "Adam Wanner", "investigatorTitle": "Professor of Medicine", "investigatorAffiliation": "University of Miami"}, "leadSponsor": {"name": "University of Miami", "class": "OTHER"}, "collaborators": [{"name": "Merck Sharp & Dohme LLC", "class": "INDUSTRY"}]}, "oversightModule": {"oversightHasDmc": false}, "descriptionModule": {"briefSummary": "Glucocorticosteroids inhibit the disposal of organic cations by blocking organic cation transporters expressed by non-neuronal cells, thereby interfering with the inactivation of the organic cations by intracellular enzymes. Beta2-adrenergic agonists are organic cations, and the concentration of inhaled beta2-adrenergic agonists at beta2-adrenergic receptor sites on smooth muscle is likely to be increased by inhaled glucocorticosteroids (ICS) by the ICS' effect on the glucocorticosteroid-sensitive organic cation transporters. The investigators have shown in human airway vascular smooth muscle cells that the glucocorticosteroid action on organic cation uptake occurs within minutes, does not involve gene transcription or protein synthesis, is not mediated through classical steroid receptors, and is cell membrane-linked.\n\nIn the present proposal, the investigators wish to use different single doses of mometasone, a clinically effective ICS, administered with or at different times before albuterol inhalation in subjects with moderate persistent asthma who are obstructed at the time of study.\n\nWith this approach the investigators will test the hypothesis that a single inhalation of mometasone causes an acute, transient, dose-dependent potentiation of beta2-adrenergic bronchodilation.\n\nIf the hypothesis that a single dose of mometasone acutely potentiates beta2-adrenergic bronchodilation is correct, the results would have a significant impact on treatment strategies involving ICSs and beta2-adrenergic agonists in patients with asthma.", "detailedDescription": "Fifteen non-smokers (males and females between the ages of 18 and 65 years) with physician-diagnosed moderate persistent asthma will be recruited for the study. The subjects will be allowed to use inhaled controller (including ICS) and rescue medication. At study entry, all asthmatic subjects must be clinically stable, and have a forced pre-bronchodilator one-second expired volume (FEV1) of \\< 75% predicted.\n\nApproval for the protocol will be requested from the University of Miami Institutional Review Board. All subjects will provide written informed consent.\n\nExclusion criteria:\n\n* Cardiovascular disease and use of cardiovascular medications\n* Pregnancy\n* Use of oral controller medication for asthma (methylxanthines, systemic glucocorticosteroids, leukotriene modifiers)\n* An acute respiratory infection within 4 weeks before enrollment.\n\nEach subject will make 8 visits to the research laboratory.\n\nProcedures:\n\nVisit 1 (screening visit): On this visit, after having signed the consent form, the subjects will perform spirometry before and 15 min after inhaling 180 \u00b5g albuterol from a HFA-MDI using a spacer.\n\nVisit 2-8:Subjects that qualify for the study will be asked to return for 7 more visits for the following treatment protocols:\n\n* Inhalation of 400 \u00b5g mometasone 30 min before inhalation of 180 \u00b5g albuterol\n* Inhalation of mometasone placebo 30 min before inhalation of 180 \u00b5g albuterol\n* Simultaneous inhalation of 400 \u00b5g mometasone and 180 \u00b5g albuterol\n* Simultaneous inhalation of mometasone placebo and 180 \u00b5g albuterol\n\nSystemic blood pressure, pulse, O2 saturation, spirometry and airway blood flow ( Qaw) will be measured before mometasone or placebo inhalation, and before and 15 min after albuterol inhalation except on the day when mometasone and albuterol are co-administered; on that day the measurements will be made before and 15 min after the mometasone/albuterol co-administration."}, "conditionsModule": {"conditions": ["Asthma"], "keywords": ["asthma,", "inhaled corticosteroids,", "airway blood flow,", "mometasone,", "albuterol", "spirometry"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["NA"], "designInfo": {"allocation": "RANDOMIZED", "interventionModel": "SINGLE_GROUP", "primaryPurpose": "OTHER", "maskingInfo": {"masking": "DOUBLE", "whoMasked": ["PARTICIPANT", "INVESTIGATOR"]}}, "enrollmentInfo": {"count": 22, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "mometasone 400 mcg - 30 min", "type": "EXPERIMENTAL", "description": "randomly assigned intervention", "interventionNames": ["Drug: mometasone 400 mcg"]}, {"label": "mometasone 400 mcg simultaneous", "type": "EXPERIMENTAL", "description": "randomly assigned intervention", "interventionNames": ["Drug: mometasone 400 mcg"]}, {"label": "placebo- 30 min", "type": "PLACEBO_COMPARATOR", "description": "randomly assigned intervention", "interventionNames": ["Drug: placebo"]}, {"label": "placebo simultaneous", "type": "PLACEBO_COMPARATOR", "description": "randomly assigned intervention", "interventionNames": ["Drug: placebo"]}, {"label": "mometasone 400 mcg - 60 min", "type": "EXPERIMENTAL", "description": "randomly assigned intervention", "interventionNames": ["Drug: mometasone 400 mcg"]}, {"label": "placebo- 60 min", "type": "PLACEBO_COMPARATOR", "description": "randomly assigned intervention", "interventionNames": ["Drug: placebo"]}, {"label": "mometasone 200 mcg - 30 min", "type": "EXPERIMENTAL", "description": "randomly assigned intervention", "interventionNames": ["Drug: mometasone 200 mcg"]}, {"label": "mometasone 200 mcg - 60 min", "type": "EXPERIMENTAL", "description": "randomly assigned intervention", "interventionNames": ["Drug: mometasone 200 mcg"]}, {"label": "mometasone 200 mcg simultaneous", "type": "EXPERIMENTAL", "description": "randomly assigned intervention", "interventionNames": ["Drug: mometasone 200 mcg"]}], "interventions": [{"type": "DRUG", "name": "placebo", "description": "placebo inhalation before albuterol.", "armGroupLabels": ["placebo simultaneous", "placebo- 30 min", "placebo- 60 min"], "otherNames": ["Asmanex placebo"]}, {"type": "DRUG", "name": "mometasone 400 mcg", "description": "mometasone inhalation before albuterol.", "armGroupLabels": ["mometasone 400 mcg - 30 min", "mometasone 400 mcg - 60 min", "mometasone 400 mcg simultaneous"], "otherNames": ["Asmanex"]}, {"type": "DRUG", "name": "mometasone 200 mcg", "description": "200ug mometasone before albuterol.", "armGroupLabels": ["mometasone 200 mcg - 30 min", "mometasone 200 mcg - 60 min", "mometasone 200 mcg simultaneous"], "otherNames": ["Asmanex"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Albuterol-induced Change in FEV1", "description": "FEV1 will be measured before and after inhalation of 180 mcg albuterol.", "timeFrame": "15 minutes after albuterol inhalation"}], "secondaryOutcomes": [{"measure": "Albuterol Induced Percent Change in Qaw", "description": "Qaw will be measured before and 15 min after albuterol inhalation", "timeFrame": "change in Qaw 15 minutes after albuterol inhalation"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:Fifteen non-smokers (males and females between the ages of 18 and 65 years) with physician-diagnosed moderate persistent asthma and FEV1 \\< 75% of predicted.\n\nExclusion Criteria:Cardiovascular disease and use of cardiovascular medications, pregnancy, use of oral controller medication for asthma (methylxanthines, systemic glucocorticosteroids, leukotriene modifiers), an acute respiratory infection within 4 weeks before enrollment\n\n-", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "18 Years", "maximumAge": "65 Years", "stdAges": ["ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "Adam Wanner", "affiliation": "University of Miami", "role": "PRINCIPAL_INVESTIGATOR"}], "locations": [{"facility": "Human Research Laboratory- University of Miami School of Medicine", "city": "Miami", "state": "Florida", "zip": "33136", "country": "United States", "geoPoint": {"lat": 25.77427, "lon": -80.19366}}]}, "referencesModule": {"references": [{"pmid": "25611803", "type": "DERIVED", "citation": "Mendes ES, Cadet L, Arana J, Wanner A. Acute effect of an inhaled glucocorticosteroid on albuterol-induced bronchodilation in patients with moderately severe asthma. Chest. 2015 Apr;147(4):1037-1042. doi: 10.1378/chest.14-1742."}]}}, "resultsSection": {"participantFlowModule": {"groups": [{"id": "FG000", "title": "All Study Participants", "description": "\u2022 Inhalation of 400 \u00b5g mometasone DPI 30 min before inhalation of 180 \u00b5g albuterol\n\nMometasone furoate: \u2022 Inhalation of 400 \u00b5g mometasone or placebo DPI 30 min before inhalation of 180 \u00b5g albuterol\n\n\u2022 Inhalation of 400 \u00b5g mometasone or placebo DPI 60 min before inhalation of 180 \u00b5g albuterol"}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "22"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "15"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "7"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "All Study Participants", "description": "\u2022 participant with asthma were enrolled in the study"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "15"}]}], "measures": [{"title": "Age, Categorical", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "<=18 years", "measurements": [{"groupId": "BG000", "value": "0"}]}, {"title": "Between 18 and 65 years", "measurements": [{"groupId": "BG000", "value": "15"}]}, {"title": ">=65 years", "measurements": [{"groupId": "BG000", "value": "0"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "9"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "6"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Albuterol-induced Change in FEV1", "description": "FEV1 will be measured before and after inhalation of 180 mcg albuterol.", "populationDescription": "As specified by the protocol, -60 minutes values were not to be analyzed if 200 mcg and 400 mcg of mometasone given 30 minutes before albuterol were determined to have no effect", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "liters", "timeFrame": "15 minutes after albuterol inhalation", "groups": [{"id": "OG000", "title": "All Participants Received 400 mcg Mometasone-30 Min", "description": "mometasone 400 mcg 30 minutes before albuterol 180 mcg inhalation"}, {"id": "OG001", "title": "All Participants Received Placebo 30 Minutes Before Albuterol", "description": "mometasone placebo 30 minutes before albuterol 180 mcg inhalation"}, {"id": "OG002", "title": "All Participants Received 400 mcg Mometasone Simultaneous", "description": "inhalation of 400 mcg mometasone immediately before inhalation of 180 mcg albuterol"}, {"id": "OG003", "title": "All Participants Received Placebo Simultaneously With Albutero", "description": "inhalation of mometasone placebo immediately before inhalation of 180 mcg albuterol."}, {"id": "OG004", "title": "All Participants Received 200 mcg Mometasone-30 Min", "description": "mometasone 200 mcg 30 minutes before inhalation of 180 mcg of albuterol"}, {"id": "OG005", "title": "All Participants Received 400 mcg -60 Min", "description": "mometasone 400 mcg 60 minutes before inhalation of 180 mcg of albuterol"}, {"id": "OG006", "title": "All Participants Received Placebo -60 Min", "description": "placebo 60 minutes before inhalation of 180 mcg of albuterol"}, {"id": "OG007", "title": "All Participants Received 200 mcg Mometasone Simultaneous", "description": "inhalation of mometasone placebo immediately before inhalation of 180 mcg albuterol"}, {"id": "OG008", "title": "All Participants Received 200 mcg -60 Min", "description": "mometasone 200 mcg 60 minutes before inhalation of 180 mcg of albuterol"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "15"}, {"groupId": "OG001", "value": "15"}, {"groupId": "OG002", "value": "15"}, {"groupId": "OG003", "value": "15"}, {"groupId": "OG004", "value": "15"}, {"groupId": "OG005", "value": "15"}, {"groupId": "OG006", "value": "15"}, {"groupId": "OG007", "value": "15"}, {"groupId": "OG008", "value": "15"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "0.27", "spread": "0.04"}, {"groupId": "OG001", "value": "0.18", "spread": "0.04"}, {"groupId": "OG002", "value": "0.32", "spread": "0.04"}, {"groupId": "OG003", "value": "0.20", "spread": "0.05"}, {"groupId": "OG004", "value": "0.23", "spread": "0.04"}, {"groupId": "OG005", "value": "NA", "spread": "NA", "comment": "Prespecified data were not analyzed due to the -30min results"}, {"groupId": "OG006", "value": "NA", "spread": "NA", "comment": "were not analyzed due to the -30min results"}, {"groupId": "OG007", "value": "NA", "spread": "NA", "comment": "were not analyzed due to the -30min results"}, {"groupId": "OG008", "value": "NA", "spread": "NA", "comment": "were not analyzed due to the -30min results"}]}]}]}, {"type": "SECONDARY", "title": "Albuterol Induced Percent Change in Qaw", "description": "Qaw will be measured before and 15 min after albuterol inhalation", "populationDescription": "As specified by the protocol, -60 minutes values were not to be analyzed if 200 mcg and 400 mcg of mometasone given 30 minutes before albuterol were determined to have no effect", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "percent change in Qaw", "timeFrame": "change in Qaw 15 minutes after albuterol inhalation", "groups": [{"id": "OG000", "title": "400 mcg Mometasone 30 Minutes Before Albuterol", "description": "\u2022 Inhalation of 400 \u00b5g mometasone 30 min before inhalation of 180 \u00b5g albuterol"}, {"id": "OG001", "title": "Mometasone Placebo 30 Minutes Before Albuterol", "description": "Inhalation of mometasone placebo 30 min before inhalation of 180 \u00b5g albuterol"}, {"id": "OG002", "title": "400 mcg Mometasone and Albuterol Simultaneously", "description": "inhalation of 400 mcg mometasone immediately before inhalation of 180 mcg albuterol."}, {"id": "OG003", "title": "Mometasone Placebo and Albuterol Simultaneously", "description": "inhalation of mometasone placebo immediately before inhalation of 180 mcg albuterol."}, {"id": "OG004", "title": "400 mcg Mometasone 60 Minutes Before Albuterol", "description": "Inhalation of 400 \u00b5g mometasone 60 min before inhalation of 180 \u00b5g albuterol"}, {"id": "OG005", "title": "Mometasone Placebo 60 Minutes Before Albuterol", "description": "Inhalation of mometasone placebo 60 min before inhalation of 180 \u00b5g albuterol"}, {"id": "OG006", "title": "200 mcg Mometasone and Albuterol Simultaneously", "description": "inhalation of 200 mcg mometasone immediately before inhalation of 180 mcg albuterol"}, {"id": "OG007", "title": "200 mcg Mometasone 60 Minutes Before Albuterol", "description": "Inhalation of 200 \u00b5g mometasone 60 min before inhalation of 180 \u00b5g albuterol"}, {"id": "OG008", "title": "200 mcg Mometasone 30 Minutes Before Albuterol", "description": "Inhalation of 200 \u00b5g mometasone 30 min before inhalation of 180 \u00b5g albuterol"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "15"}, {"groupId": "OG001", "value": "15"}, {"groupId": "OG002", "value": "15"}, {"groupId": "OG003", "value": "15"}, {"groupId": "OG004", "value": "15"}, {"groupId": "OG005", "value": "15"}, {"groupId": "OG006", "value": "15"}, {"groupId": "OG007", "value": "15"}, {"groupId": "OG008", "value": "15"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "18", "spread": "3"}, {"groupId": "OG001", "value": "0", "spread": "3"}, {"groupId": "OG002", "value": "30", "spread": "7"}, {"groupId": "OG003", "value": "-2", "spread": "3"}, {"groupId": "OG004", "value": "NA", "spread": "NA", "comment": "data not analyzed"}, {"groupId": "OG005", "value": "NA", "spread": "NA", "comment": "data not analyzed"}, {"groupId": "OG006", "value": "NA", "spread": "NA", "comment": "data not analyzed"}, {"groupId": "OG007", "value": "NA", "spread": "NA", "comment": "data not analyzed"}, {"groupId": "OG008", "value": "NA", "spread": "NA", "comment": "data not analyzed"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "0", "eventGroups": [{"id": "EG000", "title": "All Study Participants", "description": "Simultaneous inhalation of 400 \u00b5g mometasone DPI and 180 \u00b5g albuterol", "seriousNumAffected": 0, "seriousNumAtRisk": 15, "otherNumAffected": 0, "otherNumAtRisk": 15}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": true}, "pointOfContact": {"title": "Adam Wanner, MD", "organization": "University of Miami", "email": "awanner@med.miami.edu", "phone": "(305) 243-2568"}}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24"}, "conditionBrowseModule": {"meshes": [{"id": "D000001249", "term": "Asthma"}], "ancestors": [{"id": "D000001982", "term": "Bronchial Diseases"}, {"id": "D000012140", "term": "Respiratory Tract Diseases"}, {"id": "D000008173", "term": "Lung Diseases, Obstructive"}, {"id": "D000008171", "term": "Lung Diseases"}, {"id": "D000012130", "term": "Respiratory Hypersensitivity"}, {"id": "D000006969", "term": "Hypersensitivity, Immediate"}, {"id": "D000006967", "term": "Hypersensitivity"}, {"id": "D000007154", "term": "Immune System Diseases"}], "browseLeaves": [{"id": "M27137", "name": "Respiratory Aspiration", "relevance": "LOW"}, {"id": "M4556", "name": "Asthma", "asFound": "Asthma", "relevance": "HIGH"}, {"id": "M5258", "name": "Bronchial Diseases", "relevance": "LOW"}, {"id": "M14977", "name": "Respiratory Tract Diseases", "relevance": "LOW"}, {"id": "M11168", "name": "Lung Diseases", "relevance": "LOW"}, {"id": "M11170", "name": "Lung Diseases, Obstructive", "relevance": "LOW"}, {"id": "M10018", "name": "Hypersensitivity", "relevance": "LOW"}, {"id": "M14967", "name": "Respiratory Hypersensitivity", "relevance": "LOW"}, {"id": "M10020", "name": "Hypersensitivity, Immediate", "relevance": "LOW"}, {"id": "M10200", "name": "Immune System Diseases", "relevance": "LOW"}, {"id": "T170", "name": "Acute Graft Versus Host Disease", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC08", "name": "Respiratory Tract (Lung and Bronchial) Diseases"}, {"abbrev": "BC23", "name": "Symptoms and General Pathology"}, {"abbrev": "All", "name": "All Conditions"}, {"abbrev": "BC20", "name": "Immune System Diseases"}, {"abbrev": "Rare", "name": "Rare Diseases"}]}, "interventionBrowseModule": {"meshes": [{"id": "D000068656", "term": "Mometasone Furoate"}], "ancestors": [{"id": "D000000893", "term": "Anti-Inflammatory Agents"}, {"id": "D000003879", "term": "Dermatologic Agents"}, {"id": "D000018926", "term": "Anti-Allergic Agents"}], "browseLeaves": [{"id": "M3767", "name": "Albuterol", "relevance": "LOW"}, {"id": "M290", "name": "Mometasone Furoate", "asFound": "At 3", "relevance": "HIGH"}, {"id": "M20746", "name": "Adrenergic Agents", "relevance": "LOW"}, {"id": "M4217", "name": "Anti-Inflammatory Agents", "relevance": "LOW"}, {"id": "M7074", "name": "Dermatologic Agents", "relevance": "LOW"}, {"id": "M20962", "name": "Anti-Allergic Agents", "relevance": "LOW"}], "browseBranches": [{"abbrev": "Repr", "name": "Reproductive Control Agents"}, {"abbrev": "Resp", "name": "Respiratory System Agents"}, {"abbrev": "All", "name": "All Drugs and Chemicals"}, {"abbrev": "AAll", "name": "Anti-Allergic Agents"}, {"abbrev": "Infl", "name": "Anti-Inflammatory Agents"}, {"abbrev": "Derm", "name": "Dermatologic Agents"}]}}, "hasResults": true}